NCT03987997

Brief Summary

Muscles atrophy and weakness are common in intensive care units, their origin is multifactorial. Passive then active mobilization with cyclo-ergometer have shown to improve functional abilities and limit muscle weakness among intensive care unit patients. Electrical muscle stimulation should limit the atrophy and muscle weakness in intensive care unit associated with early mobilization. This study aims to compare the association early cyclo-ergometer mobilization with electrical muscle stimulation versus cyclo-ergometer mobilization only to prevent muscle atrophy and weakness in intensive care unit.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 9, 2018

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 13, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 17, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 26, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 26, 2021

Completed
Last Updated

June 17, 2019

Status Verified

June 1, 2019

Enrollment Period

3.3 years

First QC Date

May 13, 2019

Last Update Submit

June 14, 2019

Conditions

Keywords

Intensive Care UnitsCritical IllnessRehabilitationMuscle atrophyMuscle weaknessCyclo-ergometerElectrical muscle stimulation

Outcome Measures

Primary Outcomes (1)

  • Change of muscle mass of quadriceps assessed with ultrasonography

    Muscle mass of quadriceps assessed by ultrasonography. The member who receives the cyclo-ergometer mobilization alone serves as a control for the member who receives the mobilization by cyclo-ergometer and electrical muscle stimulation

    at day 0, then every 7 days (+/- 2 days) until ICU discharge (at least 6 months)

Secondary Outcomes (4)

  • Change of muscle strength of lower limb assessed by dynamometry

    at day 0, then every 7 days (+/- 2 days) until ICU discharge (at least 6 months)

  • Change of pedalling symmetry right/left

    at day 0, then every 7 days (+/- 2 days) until ICU discharge (at least 6 months)

  • Change of power variation of lower limb

    at day 0, then every 7 days (+/- 2 days) until ICU discharge (at least 6 months)

  • Change of work variation of lower limb

    Every cyclo-ergometer session, 5 days on 7 (at least 6 months)

Study Arms (2)

Association electrical muscle stimulation with cyclo-ergometer

ACTIVE COMPARATOR

Randomized leg with receive electrical muscle stimulation of the quadriceps in addition to early mobilization of lower limbs with cyclo-ergometer.

Device: Early association of electrical muscle stimulation with cyclo-ergometer

Cyclo-ergometer only

OTHER

This control group correspond to the leg which don't receive electrical muscle stimulation (as usually supported)

Device: Early association of electrical muscle stimulation with cyclo-ergometer

Interventions

Early electrical muscle stimulation in patients usually mobilized with cyclo-ergometer in ICU.

Association electrical muscle stimulation with cyclo-ergometerCyclo-ergometer only

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient affiliated to a social security scheme
  • Patient hospitalized in intensive care unit for medical or surgical reasons, under assisted ventilation (invasive, non-invasive ventilation or oxygen-therapy at high speed via the Optiflow(r) system delivering a flow between 30 and 60 L.min and a FiO2 between 30 and 100%)
  • State of the patient deemed stable buy the doctor responsible for the care and allowing the action of the physiotherapist (acts on medical prescription)
  • Age more than 18 years old (major patient) and less than 75 years old
  • Predicable duration of stay greater than or equal to 3 days

You may not qualify if:

  • Impossibility to know the consent of the patient, his legal representative or the person of trust
  • Patient under safeguard of justice, tutorship or curatorship
  • Legionnaire not rectified
  • Cardiac stimulator or defibrillator
  • Cardiorespiratory state clinically not compatible withe early mobilization
  • Neurological problems: intracranial pressure \> 20 mmHg, presence of ICU acquired neuropathy, pre-existing diagnosis of neuromuscular disease (MS, ALS...), acute stroke, epilepsy
  • Orthopedic problems: even partial amputation of a lower limb, unstable fracture, suspicion of fracture, non-fixed spinal cord injury, use of a technique that does not allow to comply with postoperative surgical instructions (range of motion, discharge...), untreated deep vein thrombosis, traumatic sequelae to the origin of disabling manifest muscle weakness of a lower limb at admission
  • Dermatological problems: severe lesions or complex dressing in the lower limbs
  • Morphological criteria : size \< 1.5m, BMI \> 35
  • Confirmed psychiatric illness or severe agitation
  • Abdominal surgery without protection by compression belt (medical prescription), or too fragile (medical opinion)
  • Patients over 75 years old
  • Hemiplegia / sequential hemiparesis
  • Impossibility to practice electrostimulation on at least one lower limb (manifest muscle weakness of a lower limb at admission (e. g. related to a traumatic sequelae)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital d'intruction des armées Clermont-Tonnerre

Brest, 29200, France

RECRUITING

MeSH Terms

Conditions

Muscle WeaknessCritical IllnessMuscular Atrophy

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsDisease AttributesAtrophyPathological Conditions, Anatomical

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Only one leg receives the electrical muscle stimulation, the leg which receives the electrical stimulation is randomized. An outcome assessor assess the outcome blindly.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Leg with electrical muscle stimulation and cycling versus leg with cycling only
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2019

First Posted

June 17, 2019

Study Start

August 9, 2018

Primary Completion

November 26, 2021

Study Completion

December 26, 2021

Last Updated

June 17, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

Locations